Skip to content
PRA

ProAssurance Corporation

ProAssurance Corporation Q3 FY2023 earnings call

November 11, 2023 · fiscal period ended 2023-09

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2023-11-11

Management highlights

Management Statement and Operational Highlights

  • Operating Loss: $0.07 operating loss due to unfavorable Workers' Compensation reserve development, but gross written premiums were up 4% quarter-over-quarter, new business was significantly higher, and retention remained strong.
  • Strategy: Relies on individual underwriting and pricing, aiming to grow profitably if disciplined in pricing and underwriting. Inflationary trends and higher loss severity affecting Specialty P&C, with proactive claims handling in Workers' Comp.
  • Segment Reorganization: Discontinued participation in Syndicate 1729, reorganized segment reporting with underwriting results from the syndicate in Specialty P&C and investment results in Corporate. Recognized $44 million noncash goodwill impairment in Workers' Compensation Insurance, no impact on operating results.
  • Investment Results: Net investment income increased 32% to $33 million due to rising interest rates. Repurchased 3 million shares in Q3 at a cost of $51 million, with remaining share repurchase authorization around $56 million.
View in transcript ↓

Segment performance

Segment Performance

  • Specialty P&C: Wrote $24 million in new business meeting pricing and underwriting standards. Renewal pricing increased 7% quarter-over-quarter, with retention in the segment at 87% (89% in Standard Physician). Underwriting expenses decreased by $4 million, resulting in an underwriting expense ratio of 25% (down nearly 2 points quarter-over-quarter).
  • Workers' Compensation Insurance: Gross written premium was $63.6 million, flat quarter-over-quarter with 2022 Q3. New business was $5 million, $1.3 million higher than last year's Q3. Renewal retention was 87% but renewal rates were down 3%. Observed higher-than-anticipated loss trends in average medical cost per claim. Underwriting expense ratio was 34% (slightly higher than prior quarter).
  • Segregated Portfolio Cell Reinsurance: Contributed a profit of just under $1 million. The combined ratio increased approximately 33 points to 128.2%, with 26 points due to tail coverage cancellation related to a program not affecting operating results.
View in transcript ↓

Guidance

Guidance

  • Workers' Comp: Need to balance decreased claim frequency with inflationary pressures. Rate declines in the broader market not as significant as ProAssurance's, with medical inflation being a key challenge.
  • Specialty P&C: Rate gains on renewal and new business, but loss side remains challenging with uncertainty. Inflationary trends and loss severity expected to impact pricing.
  • Segment Changes: Syndicate 1729 participation will be in runoff, with impact on results to be seen in next year's Q2.
View in transcript ↓

Risks

Risks

  • Inflationary Trends: Affecting loss severity in both Specialty P&C and Workers' Comp, leading to higher-than-anticipated loss trends.
  • Market Competition: Intense competition in Specialty P&C and Workers' Comp, impacting pricing and underwriting discipline.
  • Goodwill Impairment: Noncash goodwill impairment in Workers' Compensation Insurance, though not affecting operating results.
View in transcript ↓

Q&A highlights

Question and Answer

Q: View on Specialty business outlook despite worse results?

A: Edward Rand stated there's uncertainty in claims, but rate gains on renewal and improved competitor behavior are seen as positive signs.

Q: Workers' Comp rate vs pricing disconnect?

A: Edward Rand explained the difference between promulgated rates and actual pricing, noting ProAssurance is better at pricing to exposure, with medical inflation being a key challenge.

Q: Medical inflation in Workers' Comp?

A: Kevin Shook said medical inflation is pervasive, outpacing CPI and wage inflation by a wide margin, driven by labor costs in medicine and new therapies.

Q: Medical inflation in Specialty P&C?

A: Kevin Shook described higher medical trends as pervasive across the book of business, affecting various classes, geographies, and injuries.

Q: Competitive landscape in Medical Professional Liability?

A: Robert Francis mentioned mutual companies with excess capital, reinsurance market pressure on smaller carriers, and ProAssurance focusing on standard business in core states.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

November 11, 2023

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.